About ANTHEIA, INC
Antheia is a next-gen pharmaceutical ingredient manufacturer using advanced biosynthesis to produce Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) in a more efficient, agile, and sustainable manner. The company aims to transform pharmaceutical supply chains and address drug shortages through biomanufacturing.
Production of Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) using advanced biosynthesisBiomanufacturing in contained fermentation environments for reliable and consistent supplyEfficient, scalable commercial manufacturing of pharmaceutical productsEngineering complex biosynthesis pathways in yeast
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ANTHEIA, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.